A novel application of multi-wavelength TIRF spectroscopy for real time monitoring of antithrombin interactions with immobilized heparin

Biosensors and Bioelectronics

Volumn 21, Issue 10, 2006, Pages 1973-1980

  Klinth, J E ^a   Larsson, R ^b   Andersson, P O ^c   Ekdahl, K Nilsson ^a,b  

^a LINNAEUS UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c SWEDISH DEFENCE RESEARCH AGENCY   (Sweden)

Author keywords

Antithrombin; Blood compatibility; Heparinized surfaces; TIRF

Indexed keywords

ANTITHROMBIN; BLOOD COMPATIBILITY; HEPARINIZED SURFACES; TIRF;

BIOASSAY; BIOLOGICAL MATERIALS; ENZYME IMMOBILIZATION; PLASMAS; PROTEINS; SPECTROSCOPIC ANALYSIS;

POLYSACCHARIDES;

ANTITHROMBIN; HEPARIN;

ADSORPTION; CONFERENCE PAPER; ENZYME IMMUNOASSAY; FLUORESCENCE SPECTROSCOPY; HUMAN; LONG TERM EXPOSURE; PLASMA; PROTEIN INTERACTION;

ANTITHROMBINS; BIOSENSING TECHNIQUES; HEPARIN; HUMANS; SPECTROMETRY, FLUORESCENCE;

EID: 33645236294     PISSN: 09565663     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bios.2005.10.001     Document Type: Conference Paper

References (28)

1. J. Andersson, J. Sanchez, K.N. Ekdahl, G. Elgue, B. Nilsson, and R. Larsson Optimal heparin surface concentration and antithrombin binding capacity as evaluated with human non-anticoagulated blood in vitro J Biomed. Mater. Res. 67A 2003 458 466
2. L.-O. Andersson, T.W. Barrowcliffe, E. Holmer, E.A. Johnson, and G.E.C. Sims Anticoagulant properties of heparin fractionated by affinity chromatography on matrix-bound antithrombin III and by gel chromatography Thromb. Res. 9 1976 575 583
3. D. Axelrod, E. Hellen, and R. Fulbright Topics in fluorescence spectroscopy J. Lakowicz Biochemical Applications 3 1992 Plenum Press New York 289 343
4. B. Balakrishnan, D.S Kumar, Y. Yoshida, and A. Jayakrishnan Chemical modification of poly(vinyl chloride) resin using poly(ethylene glycol) to improve blood compatibility Biomaterials 26 2005 3495 3505
5. I. Björk, T.S. Olson, and J.D. Shore Molecular mechanisms of the accelerating effect of heparin on the reaction between antithrombin and clotting proteases D.D. Lane U. Lindahl Heparin, Chemical, and Biological Properties, Clinical Applications 1989 Edward Arnold London 229 255
6. K. Christensen, R. Larsson, H. Emanuelsson, G. Elgue, and A. Larsson Heparin coating of stent graft - effects on platelets, coagulation and complement activation Biomaterials 22 2001 349 355
7. R.M. Cornelius, J. Sanchez, P. Olsson, and J.L. Brash Interactions of antithrombin and proteins in the plasma contact activation system with immobilized functional heparin J. Biomed. Mater. Res. 67A 2003 475 483
8. J.M. Courtney, N.M. Lamba, S. Sundaram, and C.D. Forbes Biomaterials for blood-contacting applications Biomaterials 15 1994 737 744
9. M.B. Gorbet, and M.V. Sefton Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes Biomaterials 25 2004 5681 5703
10. J. Hong, K.N. Ekdahl, H. Reynolds, R. Larsson, and B. Nilsson A new in vitro model to study interaction between whole blood and biomaterials. Studies of platelet and coagulation activation and the effect of aspirin Biomaterials 20 1999 603 611
11. M. Höök, I. Björk, J. Hopwood, and U. Lindahl Anticoagulant activity of heparin: Separation of high-activity and low-activity heparin species by affinity chromatography on immobilized antithrombin FEBS Lett. 66 1976 90 93
12. M. Johnell, G. Elgue, R. Larsson, A. Larsson, S. Thelin, and A. Siegbahn Coagulation, fibrinolysis, and cell activation in patients and shed mediastinal blood during coronary artery bypass grafting with new heparin-coated surface J. Thorac. Cardiovasc. Surg. 124 2002 321 332
13. M. Johnell, G. Elgue, S. Thelin, R. Larsson, and A. Siegbahn Cell adhesion and tissue factor upregulation in oxygenators used during coronary artery bypass grafting are modified by the Corline Heparin Surface Scand. Cardiovasc. J. 36 2002 351 357
14. M. Johnell, R. Larsson, and A. Siegbahn The influence of different heparin surface concentrations and antithrombin-binding capacity on inflammation and coagulation Biomaterials 26 2005 1731 1739
15. K. Kaladhar, and C.P. Sharma Supported cell mimetic monolayers and their interaction with blood Langmuir 20 2004 11115 11122
16. J.R. Koegh, F.F. Velander, and J.W. Eaton Albumin-binding surfaces for implantable devices J. Biomed. Mater. Res. 26 1992 441 456
17. R. Kopp, K. Mottaghy, and M. Kirschfink Mechanisms of complement activation during extracorporeal blood-biomaterial interaction: effects of heparin coated and uncoated surfaces ASAIO J. 48 2002 598 605
18. L. Kremser, A. Bruckner, A. Heger, T. Grunert, A. Buchacher, D. Josic, G. Allmaier, and A. Rizzi Characterization of antithrombin III from human plasma by two-dimensional gel electrophoresis and capillary electrophoretic methods Electrophoresis 24 2003 4282 4290
19. E.M. Kristensen, H. Rensmo, R. Larsson, and H. Siegbahn Characterization of heparin surfaces using photoelectron spectroscopy and quartz crystal microbalance Biomaterials 24 2003 4153 4159
20. R. Larsson Heparin-binding to improve biocompatibility Encycl. Biomater. Biomed Eng. 2004 753 761
21. B. Lassen, and M. Malmsten Competitive protein adsorption at plasma polymer surfaces J. Colloid Interface Sci. 186 1997 9 16
22. U.R. Nilsson, O. Larm, B. Nilsson, K. Storm, H. Elwing, and K.N. Ekdahl Modification of the complement binding properties of polystyrene: effects of end-point heparin attachment Scand. J. Immunol. 37 1993 349 354
23. C. Nojiri, S. Kuroda, N. Saito, K.D. Park, K. Hagiwara, K. Senshu, T. Kido, T. Sugiyama, T. Kijima, and Y.H. Kim In vitro studies of immobilized heparin and sulfonated polyuretane using epifluorescent video microscopy ASAIO J. 41 1995 M389 M394
24. T.S. Olson, K.R. Srinivasan, I. Björk, and J.D. Shore Binding of high affinity heparin to antithrombin III. Stopped flow kinetic studies of the binding interaction J. Biol. Chem. 256 1981 11073 11079
25. P. Olsson, J. Sanchez, T.E. Mollnes, and J. Riesenfeld On the blood compatibility of end-point immobilized heparin J. Biomater. Sci. Polymer Edn. 11 2000 1261 1273
26. R.D. Rosenberg, and P.S. Damus The purification and mechanism of action of human antithrombin-heparin cofactor J. Biol. Chem. 248 1973 6490 6505
27. J. Wohrle, E. Al-Khayer, U. Grotzinger, C. Schindler, M. Kochs, V. Hombach, and M. Hoher Comparison of the heparin coated vs. the uncoated Jostent - no influence on restenosis or clinical outcome Eur. Heart. J. 22 2001 1808 1816
28. Z. Xu, and R.E. Marchant Adsorption of plasma proteins on polyethylene oxide-modified lipid bilayers studied by total internal reflection fluorescence Biomaterials 21 2000 1075 1083